Teachers Advisors’s Theravance Biopharma TBPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
$3.53M Buy
155,690
+1,921
+1% +$48.7K ﹤0.01% 1630
2018
Q4
$3.94M Buy
153,769
+13,954
+10% +$377K 0.01% 1452
2018
Q3
$4.57M Buy
139,815
+31,552
+29% +$860K 0.01% 1507
2018
Q2
$2.46M Buy
108,263
+2,658
+3% +$63.1K ﹤0.01% 1833
2018
Q1
$2.56M Buy
105,605
+2,817
+3% +$77.4K ﹤0.01% 1676
2017
Q4
$2.87M Buy
102,788
+31
+0% +$917 ﹤0.01% 1637
2017
Q3
$3.52M Sell
102,757
-601
-0.6% -$19.7K ﹤0.01% 1525
2017
Q2
$4.12M Buy
103,358
+23,245
+29% +$894K 0.01% 1427
2017
Q1
$2.95M Buy
80,113
+10,550
+15% +$337K ﹤0.01% 1564
2016
Q4
$2.22M Buy
69,563
+11,201
+19% +$347K ﹤0.01% 1716
2016
Q3
$2.12M Hold
58,362
﹤0.01% 1658
2016
Q2
$1.32M Buy
58,362
+8,505
+17% +$184K ﹤0.01% 1887
2016
Q1
$937K Buy
49,857
+3,368
+7% +$55.1K ﹤0.01% 2005
2015
Q4
$762K Buy
46,489
+8,981
+24% +$143K ﹤0.01% 2168
2015
Q3
$412K Hold
37,508
﹤0.01% 2509
2015
Q2
$488K Buy
37,508
+4,588
+14% +$71.2K ﹤0.01% 2544
2015
Q1
$571K Hold
32,920
﹤0.01% 2363
2014
Q4
$491K Hold
32,920
﹤0.01% 2445
2014
Q3
$759K Hold
32,920
﹤0.01% 2154
2014
Q2
$1.05M Buy
+32,920
New +$991K ﹤0.01% 2016

Other funds holding TBPH

Teachers Advisors's TBPH Position: Q1 2019 in Review

Teachers Advisors increased its Theravance Biopharma (TBPH) stake by 1.2% in Q1 2019, buying an estimated $48.7K and bringing the position to 155,690 shares worth $3.53M. The position accounts for ﹤0.01% of the portfolio, ranked #1630.

Teachers Advisors first reported a position in TBPH in Q2 2014 and has held it in 20 quarters since. The position peaked at $4.57M in Q3 2018. 104 funds tracked by Wall St. Rank hold TBPH as of Q1 2019.

  • Teachers Advisors held 155,690 shares of Theravance Biopharma worth $3.53M as of Q1 2019.
  • Teachers Advisors bought 1,921 Theravance Biopharma shares in Q1 2019, an estimated $48.7K.
  • Theravance Biopharma made up ﹤0.01% of Teachers Advisors's portfolio in Q1 2019, its #1630 holding.
  • Teachers Advisors first reported a position in Theravance Biopharma in Q2 2014 and has held it in 20 quarters since.
  • Teachers Advisors's Theravance Biopharma position peaked at $4.57M in Q3 2018.
  • 104 funds tracked by Wall St. Rank held Theravance Biopharma as of Q1 2019.

Based on Teachers Advisors's 13F filing for Q1 2019, filed 14 May 2019.